Business | 2009.09.03
Recombinant Data Corp. Implements Visionary Translational Research Solution for UMass Medical School
NEWTON, Mass.--(BUSINESS WIRE)--Recombinant Data Corp., a healthcare data warehousing and clinical intelligence solutions provider, today announced that it has implemented a translational research solution at the University of Massachusetts Medical School. The project, known as the Massachusetts Integrated Clinical Academic Research Database (MICARD), includes i2b2, an open source technology funded by the National Institutes of Health (NIH). i2b2 provides an Institutional Review Board (IRB)-comp
For more information, please visit
http://www.businesswire.com/news/home/20090902005887/en
